Regardless of the sequential decrease in Current Liabilities, during the third quarter 2017, Quick Ratio deteriorated to 0.04 above company average Quick Ratio.

Within Biotechnology & Pharmaceuticals industry 84 other companies have achieved higher Quick Ratio than Glucose Health in third quarter 2017. While Quick Ratio total ranking in the third quarter 2017 has deteriorated compared to the prior quarter from 4466 to 4478.

Explain Quick Ratio?
How much Cash & cash equivalents GLUC�s has?
What are GLUC�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GLUC Quick Ratio	(Sep 30 2017) Q3	(Jun 30 2017) Q2	(Mar 31 2017) Q1	(Dec 31 2016) Q4	(Sep 30 2016) Q3
Y / Y Current Liabilities Change	179.04 %	105.52 %	437.03 %	69.65 %	60.59 %
Y / Y Cash & cash equivalent Change	-29.51 %	-34.13 %	374.11 %	876.19 %	168.18 %
Quick Ratio MRQ	0.04	0.04	0.02	0.11	0.15
GLUC's Total Ranking	# 4478	# 4466	# 4836	#	#
Seq. Current Liabilities Change	-5.04 %	-12.13 %	198.51 %	12.02 %	-30.06 %
Seq. Cash & cash equivalent Change	-9.16 %	103.3 %	-56.06 %	-13.14 %	-15.11 %

Quick Ratio third quarter 2017 Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 85
Healthcare Sector	# 776
Overall Market	# 4478

Quick Ratio Statistics
High	Average	Low
0.04	0.03	0.02

Financial Statements
Glucose Health's Current Liabilities	$ 0 Millions	Visit GLUC's Balance sheet
Glucose Health's Cash & cash equivalent	$ 0 Millions	Visit GLUC's Balance sheet
Source of GLUC's Sales		Visit GLUC's Sales by Geography

Cumulative Glucose Health's Quick Ratio

GLUC's Quick Ratio for the trailling 12 Months

GLUC Quick Ratio	(Sep 30 2017) 12 Months	(Jun 30 2017) 12 Months	(Mar 31 2017) 12 Months	(Dec 31 2016) 12 Months	(Sep 30 2016) 12 Months
Y / Y Current Liabilities TTM Growth	174.54 %	151.92 %	172.53 %	48.19 %	17.62 %
Y / Y Cash & cash equivalent TTM Growth	16.35 %	75.91 %	375.93 %	307.73 %	165.07 %
Quick Ratio TTM	0.04	0.05	0.07	0.11	0.09
Total Ranking TTM	# 3852	# 0	# 0	#	#
Seq. Current Liabilities TTM Growth	21.31 %	21.88 %	65.22 %	12.39 %	11.31 %
Seq. Cash & cash equivalent TTM Growth	-9.75 %	-11.73 %	9.63 %	33.21 %	36.45 %

Quick ratio ranking by company, industry and sector >> Back to GLUC Financial Strength Comparisons >> Go to Compare GLUC Quick Ratio to its Competitors

On the trailing twelve months basis Due to decrease in Current Liabilities in the Q3 2017 to $0.45 millions, cumulative Quick Ratio decreased to 0.04 above the GLUC average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 61 other companies have achieved higher Quick Ratio than Glucose Health. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2017 from 0 to 3852.

Explain Quick Ratio?
How much Cash & cash equivalents GLUC�s has?
What are GLUC�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Biotechnology & Pharmaceuticals Industry	# 62
Healthcare Sector	# 622
Within the Market	# 3852

trailing twelve months Quick Ratio Statistics
High	Average	Low
0	0	0

Companies with similar Quick Ratio in the quarter ending Sep 30 2017, within Biotechnology & Pharmaceuticals Industry	Quick Ratio	Sep 30 2017 MRQ Cash & cash equivalent	Sep 30 2017 MRQ Current Liabilities
Windtree Therapeutics Inc	0.07	$ 1.752 Millions	$ 25.305 Millions
Zivo Bioscience Inc	0.07	$ 1.225 Millions	$ 18.818 Millions
Spotlight Innovation Inc.	0.06	$ 0.151 Millions	$ 2.657 Millions
Cannabis Global Inc.	0.05	$ 0.005 Millions	$ 0.094 Millions
Glucose Health, Inc.	0.04	$ 0.017 Millions	$ 0.453 Millions
Premier Biomedical Inc	0.04	$ 0.103 Millions	$ 2.885 Millions
Xtant Medical Holdings Inc	0.02	$ 2.069 Millions	$ 87.246 Millions
Zeo Scientifix Inc	0.02	$ 0.082 Millions	$ 3.881 Millions
Creative Medical Technology Holdings Inc	0.02	$ 0.021 Millions	$ 1.267 Millions
Mymetics Corporation	0.01	$ 0.830 Millions	$ 58.286 Millions

Date modified: 2026-09-08T15:09:00+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.